Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Which Comorbidities Diminish Quality of Life in Patients with MS?

Key clinical point: A higher number of comorbidities was associated with lower quality of life.

Major finding: All comorbidities accounted for 18.09% of the variance of overall health-related quality of life.

Study details: A longitudinal study of 902 patients with MS.

Disclosures: This study was supported by Multiple Sclerosis Research Australia.

Citation:

Lo LMP et al. ACTRIMS Forum 2019, Abstract 80.